UC DIS.CERT. 12/24 OMV/ DE000HD1NTB6 /
10/7/2024 11:46:55 AM | Chg.-0.060 | Bid12:17:35 PM | Ask12:17:35 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
39.080EUR | -0.15% | 39.040 Bid Size: 15,000 |
39.080 Ask Size: 15,000 |
OMV AG | - EUR | 12/31/2024 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center